OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
Lijin Lin, Ke‐Qiong Deng, Ze Chen, et al.
Atherosclerosis (2023) Vol. 372, pp. 1-9
Open Access | Times Cited: 13
Lijin Lin, Ke‐Qiong Deng, Ze Chen, et al.
Atherosclerosis (2023) Vol. 372, pp. 1-9
Open Access | Times Cited: 13
Showing 13 citing articles:
Lipoprotein(a) and cardiovascular disease
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 18
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 18
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 11, pp. 1525-1546
Open Access | Times Cited: 16
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 11, pp. 1525-1546
Open Access | Times Cited: 16
LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics
Erfan Tasdighi, Rishav Adhikari, Omar Almaadawy, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 135-157
Closed Access | Times Cited: 13
Erfan Tasdighi, Rishav Adhikari, Omar Almaadawy, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 135-157
Closed Access | Times Cited: 13
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Lipoprotein (a) Distribution in Aortic Stenosis Patients
Michael-Roy R. Durr, Ian G. Burwash, Lawrence Lau, et al.
JACC Advances (2025) Vol. 4, Iss. 4, pp. 101662-101662
Closed Access
Michael-Roy R. Durr, Ian G. Burwash, Lawrence Lau, et al.
JACC Advances (2025) Vol. 4, Iss. 4, pp. 101662-101662
Closed Access
Prevalence, awareness, treatment, and control of dyslipidemia in Chinese adults: a systematic review and meta-analysis
Qianhang Xia, Yuquan Chen, Zijing Yu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
Qianhang Xia, Yuquan Chen, Zijing Yu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Lijin Lin, Yulian Hu, Lei Fang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Lijin Lin, Yulian Hu, Lei Fang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
Madalena Rosário, Ana Catarina Fonseca
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1251-1251
Open Access | Times Cited: 9
Madalena Rosário, Ana Catarina Fonseca
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1251-1251
Open Access | Times Cited: 9
Measuring lipoprotein(a) for cardiovascular disease prevention – in whom and when?
P. E. Thomas, Signe Vedel‐Krogh, Børge G. Nordestgaard
Current Opinion in Cardiology (2023) Vol. 39, Iss. 1, pp. 39-48
Closed Access | Times Cited: 5
P. E. Thomas, Signe Vedel‐Krogh, Børge G. Nordestgaard
Current Opinion in Cardiology (2023) Vol. 39, Iss. 1, pp. 39-48
Closed Access | Times Cited: 5
Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China
Pingting Yang, Li Tang, Huirong Guo, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Pingting Yang, Li Tang, Huirong Guo, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Update on Biomarkers Associated with Large Artery Atherosclerosis Stroke
Madalena Rosário, Ana Catarina Fonseca
(2023)
Open Access | Times Cited: 2
Madalena Rosário, Ana Catarina Fonseca
(2023)
Open Access | Times Cited: 2
Lipoprotein(a) and Atrial Fibrillation: Mechanistic Insights and Therapeutic Approaches
Zixi Zhang, Bo Peng, Akedanmu Nuranmubieke, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 2, pp. 357-370
Open Access
Zixi Zhang, Bo Peng, Akedanmu Nuranmubieke, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 2, pp. 357-370
Open Access
